WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (NASDAQ:NURO) announced today that Shai N. Gozani
M.D., Ph.D., President and Chief Executive Officer, is scheduled to
speak at the Source Capital Group's 2016 Disruptive Growth & Healthcare
Conference at the Convene Conference Center in New York, NY on February
11, 2016. Dr. Gozani intends to provide an update on the Company's
business activities including the Quell® Wearable Pain Relief
Technology™.
NeuroMetrix's presentation is scheduled for Thursday, February 11, 2016
at 9:30 a.m. Eastern time. A live audio and slide webcast will be
available on the investor relations section of the corporate website, www.NeuroMetrix.com.
This webcast will be archived after the live event.
About Source Capital Group
Source Capital Group, Inc. was founded in 1992 on the belief that the
best investment advice should be independent, unbiased and tailor-made
for the individual client's needs. Source Capital began as a boutique
investment banking firm specializing in small to medium sized
transactions. It has grown to include businesses in general securities,
emerging market securities, distressed and high yield debt securities,
in addition to its investment banking activity. For more information,
please visit http://www.sourcegrp.com/.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160204005275/en/
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
